Prospectus Supplement No. 2
PROSPECTUS SUPPLEMENT NO. 2
(TO PROSPECTUS DATED JUNE 5, 2006) 		Filed Pursuant to Rule 424(b)(7)
Registration No. 333-134728

$250,000,000
CONEXANT SYSTEMS, INC.

4% CONVERTIBLE SUBORDINATED NOTES DUE 2026
SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THE NOTES

            This prospectus supplement no. 2 supplements and amends the prospectus dated June 5, 2006, as previously supplemented and amended by prospectus supplement no. 1 (as so supplemented and amended, the “prospectus”), relating to the resale from time to time by certain selling securityholders of our 4% convertible subordinated notes due 2026 and shares of our common stock issuable upon conversion of the notes.

            This prospectus supplement should be read in conjunction with and accompanied by the prospectus and is qualified by reference to the prospectus, except to the extent that the information in this prospectus supplement supersedes the information contained in the prospectus.

            The information appearing in the table below, which is based on information provided by or on behalf of the named selling securityholders, supplements and amends the information in the table appearing under the heading “Selling Securityholders” in the prospectus. The percentage of notes outstanding beneficially owned by each selling securityholder is based on $250,000,000 aggregate principal amount of notes outstanding. The number of shares of common stock owned prior to the offering includes shares of common stock issuable upon conversion of the notes. The number of shares of common stock offered hereby is based on the initial conversion rate of 203.2520 shares of common stock per $1,000 principal amount of notes and a cash payment in lieu of any fractional share.


Selling Securityholder    Principal Amount of Notes Beneficially Owned and Offered Hereby (1) Percentage of Notes Outstanding Common Stock Owned Prior to the Offering Common Stock Offered Hereby
1976 Distribution Trust FBO A.R.
      Lauder/Zinterhofer		 $ 5,000    *    1,016    1,016 
2000 Revocable Trust FBO A.R.
      Lauder/Zinterhofer		   4,000    *    813    813 
Advent Convertible Master Fund   5,354,000    2.1%    1,088,211    1,088,211 
Alcon Laboratories   390,000    *    79,268    79,268 
Arlington County Employees Retirement System   571,000    *    116,056    116,056 
City University of New York   114,000    *    23,170    23,170 
Grady Hospital Foundation   109,000    *    22,154    22,154 
Greenwich International, Ltd. (2)   3,000,000    1.2%    963,901    609,756 
HFR CA Opportunity Fund   412,000    *    83,739    83,739 
HFR CA Select Fund (3)   1,200,000    *    243,902    243,902 
Institutional Benchmarks Series (Master Feeder)
      Ltd. (3)		   1,400,000    *    284,552    284,552 
Lyxor   234,000    *    47,560    47,560 
New Orleans Firefighters Pension/Relief Fund   67,000    *    13,617    13,617 
Occidental Petroleum Corporation   254,000    *    51,626    51,626 
Pro Mutual   720,000    *    146,341    146,341 
San Diego County Employee Retirement
      Association (3)		   2,750,000    1.1%    558,943    558,943 
San Francisco City and County ERS   1,128,000    *    229,268    229,268 
Zazove Convertible Arbitrage Fund, L.P.   6,100,000    2.4%    1,239,837    1,239,837 
Zazove Hedged Convertible Fund, L.P.   4,000,000    1.6%    813,008    813,008 
 

* Less than one percent of the notes outstanding.

(1)  We believe that any excess of the total amount of registered sales by selling securityholders is the result of (i) sales by selling securityholders who previously registered their securities in unregistered exempt transactions and the subsequent registration by the purchasers thereof, or (ii) registration by selling securityholders who had acquired their securities in a previously registered transaction.

(2)  This selling securityholder is an affiliate of a registered broker-dealer and, therefore, may be deemed an underwriter by the SEC.

(3)  Zazove Associates, LLC acts as investment advisor with discretionary authority for this selling securityholder.

            Investing in the notes and the underlying shares of common stock involves significant risks. See “Risk Factors” beginning on page 5 of the prospectus.

            Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the prospectus. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is June 20, 2006.